Remove Healthcare Provider Remove Networking Remove Pharma Remove Transportation
article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In 2023, pharmaceutical companies must unlearn the old lessons of commercial engagement, where frequency and face-to-face were key, and focus on the quality of meaningful interaction, where a healthcare professional’s attention is fully engaged and the experience is meaningful to their work. Medicines manufacturing is energy intensive.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

These developments, together with Walgreens’ recent rollout of Health Corners that help patients manage chronic conditions and its October 2022 announcement that it would fully acquire CareCentrix (a platform that coordinates post-acute and home care), underscore Walgreens’ plans to become a leading healthcare provider.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

In this blog, we take a close look at health equity in oncology trials specifically, assessing how the lack of diversity and inclusion has impacted cancer patients and the pharma industry’s key initiatives to address it. J National Comprehensive Cancer Network. Clarify launched its real-world evidence on health disparities in 2021.

article thumbnail

Putting Patients First: Improving the Pharmaceutical Supply Chain

Impetus Digital

This could mean anything from developing policies that promote fairness and transparency in pricing to creating networks of distribution points that ensure medications can be delivered promptly wherever needed.